VETNOSTRUM ANIMAL HEALTH CO LTD

Total Valuation

VETNOSTRUM ANIMAL HEALTH CO LTD carries a market capitalization of 2.33B, placing it among publicly traded companies globally. Its enterprise value stands at 2.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

VETNOSTRUM ANIMAL HEALTH CO LTD currently has 72.76M shares outstanding.

Valuation Ratios

VETNOSTRUM ANIMAL HEALTH CO LTD trades at a trailing price-to-earnings ratio of 20.49. The price-to-sales ratio is 1.94, and the price-to-book ratio stands at 2.20.

Enterprise Valuation

On an enterprise value basis, VETNOSTRUM ANIMAL HEALTH CO LTD trades at an EV/EBITDA multiple of 15.12 and an EV/FCF ratio of 11.44. The EV/Sales ratio of 1.84 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.12 provides insight into valuation relative to core operating earnings.

Financial Position

VETNOSTRUM ANIMAL HEALTH CO LTD maintains a current ratio of 2.69, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.87, indicating elevated leverage, while an interest coverage ratio of 208.73 demonstrates strong ability to service its debt obligations.

Financial Efficiency

VETNOSTRUM ANIMAL HEALTH CO LTD posts a return on equity of 11.05 and a return on invested capital of 10.72.

Taxes

Over the trailing twelve months, VETNOSTRUM ANIMAL HEALTH CO LTD has paid 31.10M in income taxes, reflecting an effective tax rate of 19.50.

Stock Price Statistics

VETNOSTRUM ANIMAL HEALTH CO LTD's stock has declined approximately -9.59097% over the past 52 weeks. The 50-day moving average sits at 32.50, while the 200-day moving average is 34.37.

Income Statement

Over the trailing twelve months, VETNOSTRUM ANIMAL HEALTH CO LTD generated 1.35B in revenue and converted that into 128.40M in net income, yielding earnings per share of 1.87. EBITDA reached 164.48M, while operating income came in at 164.48M.

Balance Sheet

VETNOSTRUM ANIMAL HEALTH CO LTD holds 330.04M in cash and equivalents against 23.75M in total debt, resulting in a net debt position of -110.04M. Total book value stands at 1.27B, with working capital of 607.17M providing operational flexibility.

Cash Flow

VETNOSTRUM ANIMAL HEALTH CO LTD produced 193.62M in operating cash flow over the past twelve months. After subtracting -23.20M in capital expenditures, free cash flow totaled 170.42M - equivalent to 2.49 per share.

Margins

VETNOSTRUM ANIMAL HEALTH CO LTD operates with a gross margin of 32.74, reflecting its pricing power and cost economics. The operating margin of 12.14 and net profit margin of 9.48 provide insight into operational efficiency.

Dividends & Yields

Scores

VETNOSTRUM ANIMAL HEALTH CO LTD posts an Altman Z-Score of 6.21, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.